Form 4 Tracker
BridgeBio Pharma, Inc.
BBIO

45 insider filings · Latest: Sep 17, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 17, 2026Sep 21 10:21 PMNeil KumarDirector, Chief Executive Officer
Sale
10,000$69.08$690.8K495,686(I)

View →

Aug 19, 2026Aug 20 8:31 PMNeil KumarDirector, Chief Executive Officer
Sale
10,000$84.03$840.3K505,686(I)

View →

Aug 18, 2026Aug 20 8:31 PMNeil KumarDirector, Chief Executive Officer
Sale
34,980$82.53$2.9M243,327(D)

View →

Aug 19, 2026Aug 19 8:34 PMKUMAR HALDEA FAMILY IRREVOCABLE TRU/T/A DTD 05/18/2019
Proposed Sale
30,000$82.98$2.5M—

View →

Aug 18, 2026Aug 18 8:26 PMNEIL KUMAR
Proposed Sale
34,980$79.89$2.8M—

View →

Aug 17, 2026Aug 17 8:32 PMRANDAL SCOTT
Proposed Sale
21,501$79.86$1.7M—

View →

Jul 30, 2026Aug 3 8:20 PMMaricel ApuliChief Accounting Officer
Sale
2,000$80.06$160.1K127,401(D)

View →

Jul 9, 2026Jul 13 8:41 PMAndrea EllisDirector
Sale
17,167$84.00$1.4M22,579(D)

View →

Jul 9, 2026Jul 13 8:40 PMJennifer E. CookDirector
Sale
148,589$88.54$13.2M8,383(D)

View →

Jul 9, 2026Jul 9 8:22 PMJENNIFER COOK
Proposed Sale
148,589$88.54$13.2M—

View →

Jul 9, 2026Jul 9 8:11 PMANDREA ELLIS
Proposed Sale
17,167$84.00$1.4M—

View →

Jun 24, 2026Jun 24 10:06 PMJennifer E. CookDirector
Sale
37,167$70.00$2.6M8,383(D)

View →

Jun 23, 2026Jun 24 10:06 PMJennifer E. CookDirector
Sale
2,196$68.57$150.6K8,383(D)

View →

Jun 23, 2026Jun 24 10:06 PMHannah ValantineDirector
Sale
2,196$68.57$150.6K9,259(D)

View →

Jun 22, 2026Jun 24 10:06 PMHannah ValantineDirector
Sale
2,808$68.00$190.9K11,455(D)

View →

Jun 24, 2026Jun 24 8:34 PMRANDAL SCOTT
Proposed Sale
2,196$68.63$150.7K—

View →

Jun 24, 2026Jun 24 8:08 PMJENNIFER COOK
Proposed Sale
37,167$70.00$2.6M—

View →

Jun 23, 2026Jun 23 8:33 PMJENNIFER COOK
Proposed Sale
2,196$68.57$150.6K—

View →

Jun 23, 2026Jun 23 8:02 PMHANNAH A VALANTINE
Proposed Sale
2,196$68.57$150.6K—

View →

Jun 22, 2026Jun 22 8:06 PMHANNAH A VALANTINE
Proposed Sale
2,808$68.00$190.9K—

View →

Page 1 of 5

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 17, 2026Mar 19 8:28 PMNeil KumarDirector, Chief Executive Officer
Grant/Award
144,883$70.94104,313(D)

View →

Mar 10, 2026Mar 12 8:15 PMHannah ValantineDirector
Option Exercise
8,671$27.3617,343(D)

View →

Mar 4, 2026Mar 6 9:57 PMAndrea EllisDirector
Option Exercise
64,921$8.450(D)

View →

Feb 27, 2026Mar 3 9:17 PMHannah ValantineDirector
Option Exercise
25,484$48.450(D)

View →

Feb 16, 2026Feb 18 11:41 PMNeil KumarDirector, Chief Executive Officer
Option Exercise
64,698—138,645(D)

View →

Feb 17, 2026Feb 18 11:34 PMRandal W. ScottDirector
Option Exercise
10,000$16.7531,501(D)

View →

← Previous

Page 2 of 2